# Efficacy of Mw Vaccine in Treatment of Severe Sepsis

> **NCT02025660** · PHASE2,PHASE3 · COMPLETED · sponsor: **Post Graduate Institute of Medical Education and Research, Chandigarh** · enrollment: 50 (actual)

## Conditions studied

- Severe Sepsis
- Septic Shock
- Immune Modulation

## Interventions

- **DRUG:** Mw, 0.3ml x three days sc
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02025660
- **Lead sponsor:** Post Graduate Institute of Medical Education and Research, Chandigarh
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-08
- **Primary completion:** 2014-02
- **Final completion:** 2014-03
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2014-03-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02025660

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02025660, "Efficacy of Mw Vaccine in Treatment of Severe Sepsis". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT02025660. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*